IMPROVING LIVES THROUGH INNOVATION AND CARE Dr. Sudhir SrivastavaFounder, Chairman and CEOSS Innovations has been involved in the field of medical robotic technology over the past decade. Founder,Chairman and CEO, Dr. Sudhir Srivastava, has made it his personal mission to find ways to improve gold standard surgical procedures through the union of great skill, patient care, and continually advancing technologies. By pushing the limits of technology, SS Innovations aims to improve the quality of medical services for patients all over the world.At SS Innovations, we are pioneering the future of medical robotics by leveraging cutting-edge technology, renowned surgeons, and world-class training to drive advancements in the field of surgery. Our commitment to excellence and innovation in robotic surgery ensures we are at the forefront of healthcare transformation.SS Innovations is leading the way in making surgical robotics more accessible. Our robotic system is the first of its kind in India—cost-effective, versatile, and capable of transforming surgical practices. With applications across various specialties, including cardiac surgery, we are committed to providing cutting-edge solutions to underserved populations that lack access to less invasive surgical technologies.Dr. Srivastava, along with ten additional physicians, founded Alliance Hospital LTD, a center of excellence in the treatment of cardiovascular disease, in Odessa, Texas in July 2003 and served as its chairman for four years. While there, he performed the world’s first single vessel beating heart TECAB in the United States. He also proceeded to perform two world’s first double and triple vessel TECAB on a beating heart and is the only person in the world to have performed a quadruple vessel beating heart TECAB while at the University of Chicago.Dr. Srivastava has made it his mission to make available his skill to all those with the desire to learn these minimally invasive techniques. Dr. Srivastava has trained hundreds of teams around the world and is constantly trying to find ways to improve the field of robotic assisted surgery.Dr. Moll’s career began in surgical residency at Virginia Mason Medical Center, where he saw the potential to minimize surgical invasiveness. This realization led him to develop the safety trocar, enabling safer laparoscopic procedures. Following this innovation, he launched and led several successful medical device companies. Among his earliest ventures were Endotherapeutics and Origin Medsystems, both acquired by major corporations and instrumental in advancing laparoscopic surgery.In 1995, Dr. Moll co-founded Intuitive Surgical, where he co-developed the groundbreaking da Vinci robotic-assisted surgery system, which remains a global standard for minimally invasive surgery. He continued his pioneering work by founding Hansen Medical, focusing on robotic technology for vascular and electrophysiology procedures, and later, Auris Health, where he developed the Monarch platform for robotic endoscopy. This innovative technology, acquired by Johnson & Johnson in 2019, advanced the diagnosis and treatment of lung cancer.Dr. Moll has served on the boards of several influential healthcare technology companies, including Mako Surgical and RefleXion, where he has championed innovations in robotic surgery and cancer treatment. With decades of experience and a commitment to revolutionizing healthcare, Dr. Moll’s contributions have left a lasting impact on medical technology and patient care worldwide.Barry Cohen is currently the Chief Operating Office of the Americas for Sudhir Srivastava Innovations Pvt. ltd. After the merger between SSInnovations and Avra Medical Robotics Inc. He also serves as the Chairman of the Board at Avra Medical Robotics Inc. Mr. Cohen founded the company and has served as its Chief Executive Officer and director since February 4, 2015. Between 2006 and 2008, Mr. Cohen was a private investor and founded Avra Surgical, Inc. a medical technology company. From approximately 1979 to 1989, he served as director of Synalloy Corp., a manufacturer of pipe, piping systems and specialty chemicals after which he was appointed to serve as President from 1984 to 1985. Mr. Cohen also served as Chairman of the executive Board of Wolverine Technologies, Inc., a NYSE listed company from 1979 to 1983 and President Barry F. Cohen & Co., an NASD member from 1983 to 1999. Mr. Cohen has over 50 years of experience in managing private and public industrial companies, and 47 years experience as a securities manager.Dr Somashekhar who did his MBBS from Mysore University, MS (Gen. Surgery) from NHL Medical College, MCh (Surgical Oncology) from GCRI Regional Cancer Centre has various other academic accomplishments including Fellowship in Robotic Surgery from Roswell Cancer Centre, Buffalo, USA. He had training in Gynaecological Oncology at Mayo Clinic, Rochester, Advanced Liver Surgery at Paul Brouses Hospital, Paris, Thoracic Onco Fellowship at Shanghai Chest Institute Beijing, Breast & Oncoplasty Fellowship from IEO Italy and UPMC Pittsburgh. He has performed over 3000 Robotic Surgeries which is the highest number of complex Robotic Onco Surgeries in the country and over 1000 HIPEC procedure in abdominal cancers, which is the largest series in Asia. He was instrumental in introducing SLNB Sentinel Node Biopsy in India way back in 2001.Prof. Dr. Somashekhar has been awarded the prestigious Dr. D. D. Patel Gold Medal for his excellency in Onco Surgery and a Fellow from the Royal College of Surgeons, Edinburgh. He has authored several textbooks on Oncology and has over 300 publications in International and National Journals. He has been honoured with the prestigious Dronacharya Teachers Award for his contribution in the field of Surgical Oncology. He has also been awarded the Times Award for Excellence in Oncology, the Deccan Herald Excellency Award in Oncology, and the prestigious ASI P K Sinha Oration Award. He has been invited for the most prestigious orations in Royal College of Surgeons and Gynaecological Oncology, UK, Canada, Australia and US. He is conferred the most prestigious Bulkley-Barry-Cooper Professorship: Kings Health Partner, UK, London. He is also ex-Adjunct Professor Surgical Oncology, KMC University. He has trained over 134 surgical students in various sub-specialities. He is also Teacher and University Examiner in the field of Surgical Oncology for both MCh and DrNB Surgical Oncology (NBE board). He is Intuitive International Mentor and Trainer in the field of Robotic Surgery.Before joining Aster, Prof. Dr. Somashekhar S P worked with Manipal Group of Hospitals as Chairman, Oncology, MHEPL and Manipal Comprehensive Cancer Center, HOD Department of Surgical & Gynec. Oncology, Bangalore and as Member Board of Studies, Manipal University, Manipal and Director of Breast Surgery & Oncoplasty, Robotic Surgery and Gynaecological Oncology University Fellowship Programs. He is the Ex-President of ABSI Association of Breast Surgeons of India, and Editor in Chief at Springer Indian Journal of Gynec Onco, Editor of Annals of Breast Diseases Journal, EC Council Member of PSOGI (Peritoneal Surface Oncology Group International) and Council Member of ISSPP (International Society Study of Peritoneum and Pleural), Council Member of AGOI (Association of Gynaec Oncology India), Hon. Secretary of ISPSM (Indian Society of Peritoneal Surface Malignancy) and Founding Member of CRSA-I (Clinical Robotic Surgeons Association India), Office Bearer of Indian Association of Surgical Oncologist and Association of Gynec. Oncologists of India.